At a glance
- Originator Bristol-Myers Squibb
- Class Antiarrhythmics; Benzoic acids; Fluorobenzenes; Propanolamines; Small molecules
- Mechanism of Action Beta-adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Ischaemic heart disorders